IL6 and autoimmune disease: IL-6 trans--signalling is thought to be responsible for most of the pathogenetic effects of IL-6 and is implicated in autoimmune diseases like rheumatoid arthritis and irritable bowel disease (Jarlborg and Gabay, 2022; Schreiber et al., 2021).